Summary of results of studies included in the systematic review
| Study | O'Keefe (1992)11 | Deftereos (2013)12 | CISR (2019)13 | Colcot (2019)14 | LoDoCo-MI (2019)15 | Colchicine-PCI (2020)16 | COPS (2020)17 |
| N (T/C) | 197 (130/67) | 196 (100/96) | 90 (A: 30/B: 30 /C: 30) | 4745 (2366/2379) | 237 (119/118) | 400 (206/194) | 795 (396/399) |
| In-stent restenosis, TvC (%) | 41.0v45.0 | Angio-ISR: 16.0v33.0 IVUS-ISR: 24.0v43.0 | 3.3v23.3v0 | N/A | N/A | N/A | N/A |
| Repeat vessel revascularisation, TvC (%) | N/A | 4.0v5.2 | 3.3v26.7v0 | 1.1v2.1 | N/A | N/A | 0.8v3.0 |
| Stent thrombosis, TvC (%) | N/A | N/A | 0v1.7 | N/A | 0v0.8 | N/A | 2.8v5.5 |
| Stroke, TvC (%) | N/A | 1v0 | N/A | 0.2v0.8 | N/A | 1v0 | 0.5v1.5 |
| Resuscitated cardiac arrest, TvC (%) | N/A | N/A | N/A | 0.2v0.3 | N/A | N/A | N/A |
| All-cause mortality, TvC (%) | 0.8v3.0 | 1.0v1.0 | N/A | 1.8v1.8 | 0 (0.00) | 0.5v0.5 | 2.0v3.0 |
CISR 2019: A-Bare metal stent +colchicine.
CISR, Colchicine Treatment for Prevention of in Stent Restenosis; Colchicine-PCI, Colchicine in Percutaneous Coronary Intervention; COPS, Colchicine for Patients with Acute Coronary Syndrome; ISR, in-stent restenosis; IVUS, intravascular ultrasound; LoDoCo-MI, The Low Dose Colchicine after Myocardial Infarction ; MI, myocardial infarction; N/A, not available; PCI, percutaneous coronary intervention; TvC, treatment vs control.